Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2013-12-10

Clinical Trial Update: Input of the Use of Indometacin in Gitelman Syndrome as Compared to Potassium Sparing Diuretics [Phase 1, Phase 2]

View source ↗

Summary

This clinical trial update reports on the use of indometacin in Gitelman syndrome, compared with potassium-sparing diuretics, in Phase 1 and Phase 2 studies wit…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Indometacin (Indomethacin)

Snippet

Sponsor: Assistance Publique - Hôpitaux de Paris | Conditions: Gitelman Syndrome | Phase 1, Phase 2 | Status: COMPLETED